MRLs for sodium salicylate in poultry
- Food safety
- Veterinary residues
Summary
The EU has set maximum residue levels (MRLs) for sodium salicylate in tissues of poultry other than turkey. Sodium salicylate may not be used in poultry producing eggs for human consumption.
EU sets MRLs for sodium salicylate in chicken and poultry (other than turkey)
Commission Implementing Regulation (EU) 2024/859 of 18 March 2024 amending Regulation (EU) No 37/2010 as regards the classification of the substance sodium salicylate with respect to its maximum residue limit in foodstuffs of animal origin
Update
The EU has set maximum residue levels (MRLs) for sodium salicylate in tissues of poultry other than turkey. Sodium salicylate may not be used in poultry producing eggs for human consumption.
Impacted Products
poultry
What is changing?
The EU has now set the following MRLs for sodium salicylate in tissues of poultry (other than turkey):
- muscle, and skin and fat in natural proportion: 250 μg/kg
- liver: 500 μg/kg
- kidney: 1000 μg/kg.
MRLs for sodium salicylate in turkey were already set under Regulation 37/2010.
Sodium salicylate may not be used in poultry that is producing eggs for human consumption.
Why?
The European Medicines Agency (EMA) concluded that the MRLs for sodium salicylate from chicken tissues can be extended to those of other poultry (except turkey, for which MRLs are already in place). Sodium salicylate may not be used in poultry producing eggs because inadequate data has been submitted relating to egg consumption.
Timeline
The new MRLs will apply from 8 April 2024.
Background
The Annex to Regulation 37/2010 sets MRLs for sodium salicylate in turkey. No MRL is required for oral use of sodium salicylate in cattle and pigs. The substance is not allowed for oral use in animals producing milk for human consumption.
In September 2022, Dopharma B.V. submitted an application to the EMA for the use of sodium salicylate in chicken. In October 2023 the EMA, based on the opinion of the Committee for Veterinary Medicinal Products, recommended that MRLs be set for its use in chicken, and that these MRLs should apply also to other poultry except turkey (for which MRLs were already in place).
Resources
Online resources from the European Commission:
- Control plans for residues of veterinary medicines, pesticides and contaminants
- Residues of veterinary medicinal products
Regulation 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin
Sources
Commission Implementing Regulation (EU) 2024/859 as regards the classification of the substance sodium salicylate with respect to its maximum residue limit in foodstuffs of animal origin
Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.
EU sets MRLs for sodium salicylate in chicken and poultry (other than turkey)
Regulation
Commission Implementing Regulation (EU) 2024/859 as regards the classification of the substance sodium salicylate with respect to its maximum residue limit in foodstuffs of animal origin
What is changing and why?
The EU has now set the following maximum residue levels (MRLs) for sodium salicylate in tissues of poultry (other than turkey):
- muscle, and skin and fat in natural proportion: 250 μg/kg
- liver: 500 μg/kg
- kidney: 1000 μg/kg.
MRLs for sodium salicylate in turkey were already set under Regulation 37/2010.
Sodium salicylate may not be used in poultry that is producing eggs for human consumption, due to a lack of data on egg consumption.
Timeline
The new MRLs will apply from 8 April 2024.
Disclaimer: Under no circumstances shall COLEAD be liable for any loss, damage, liability or expense incurred or suffered that is claimed to have resulted from the use of information available on this website or any link to external sites. The use of the website is at the user’s sole risk and responsibility. This information platform was created and maintained with the financial support of the European Union. Its contents do not, however, reflect the views of the European Union.